15 results on '"Erschow, Sergej"'
Search Results
2. Vitamin A preserves cardiac energetic gene expression in a murine model of diet-induced obesity
- Author
-
Naasner, Lea, primary, Froese, Natali, additional, Hofmann, Winfried, additional, Galuppo, Paolo, additional, Werlein, Christopher, additional, Shymotiuk, Ivanna, additional, Szaroszyk, Malgorzata, additional, Erschow, Sergej, additional, Amanakis, Georgios, additional, Bähre, Heike, additional, Kühnel, Mark P., additional, Jonigk, Danny D., additional, Geffers, Robert, additional, Seifert, Roland, additional, Ricke-Hoch, Melanie, additional, Wende, Adam R., additional, Blaner, William S., additional, Abel, E. Dale, additional, Bauersachs, Johann, additional, and Riehle, Christian, additional
- Published
- 2022
- Full Text
- View/download PDF
3. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
- Author
-
Pfeffer, Tobias J., primary, Mueller, Julia H., additional, Haebel, Lea, additional, Erschow, Sergej, additional, Yalman, Kuebra C., additional, Talbot, Steven R., additional, Koenig, Tobias, additional, Berliner, Dominik, additional, Zwadlo, Carolin, additional, Scherr, Michaela, additional, Hilfiker‐Kleiner, Denise, additional, Bauersachs, Johann, additional, and Ricke‐Hoch, Melanie, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models
- Author
-
Schiffer, Mario, Teng, Beina, Gu, Changkyu, Shchedrina, Valentina A., Kasaikina, Marina, Pham, Vincent A., Hanke, Nils, Rong, Song, Gueler, Faikah, Schroder, Patricia, Tossidou, Irini, Park, Joon-Keun, Staggs, Lynne, Haller, Hermann, Erschow, Sergej, Hilfiker-Kleiner, Denise, Wei, Changli, Chen, Chuang, Tardi, Nicholas, Hakroush, Samy, Selig, Martin K., Vasilyev, Aleksandr, Merscher, Sandra, Reiser, Jochen, and Sever, Sanja
- Subjects
Chronic kidney failure -- Models -- Causes of -- Development and progression -- Genetic aspects -- Research ,Actin -- Models -- Physiological aspects -- Genetic aspects -- Research ,Biological sciences ,Health - Abstract
Dysregulation of the actin cytoskeleton in podocytes represents a common pathway in the pathogenesis of proteinuria across a spectrum of chronic kidney diseases (CKD). The GTPase dynamin has been implicated in the maintenance of cellular architecture in podocytes through its direct interaction with actin. Furthermore, the propensity of dynamin to oligomerize into higher-order structures in an actin-dependent manner and to cross-link actin microfilaments into higher-order structures has been correlated with increased actin polymerization and global organization of the actin cytoskeleton in the cell. We found that use of the small molecule Bis-T-23, which promotes actin-dependent dynamin oligomerization and thus increased actin polymerization in injured podocytes, was sufficient to improve renal health in diverse models of both transient kidney disease and CKD. In particular, administration of Bis-T-23 in these renal disease models restored the normal ultrastructure of podocyte foot processes, lowered proteinuria, lowered collagen IV deposits in the mesangial matrix, diminished mesangial matrix expansion and extended lifespan. These results further establish that alterations in the actin cytoskeleton of kidney podocytes is a common hallmark of CKD, while also underscoring the substantial regenerative potential of injured glomeruli and identifying the oligomerization cycle of dynamin as an attractive potential therapeutic target to treat CKD., Chronic kidney disease (CKD) affects hundreds of millions of people worldwide (1,2). It is associated with the appearance of significant amounts of high-molecular-weight plasma proteins in the urine (that is, [...]
- Published
- 2015
- Full Text
- View/download PDF
5. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
- Author
-
Pfeffer, Tobias J., Mueller, Julia H., Haebel, Lea, Erschow, Sergej, Yalman, Kuebra C., Talbot, Steven R., Koenig, Tobias, Berliner, Dominik, Zwadlo, Carolin, Scherr, Michaela, Hilfiker‐Kleiner, Denise, Bauersachs, Johann, and Ricke‐Hoch, Melanie
- Subjects
PERIPARTUM cardiomyopathy ,CABERGOLINE ,PLASMINOGEN activator inhibitors ,CARDIAC hypertrophy ,DOPAMINE receptors ,BROMOCRIPTINE - Abstract
Aims: Peripartum cardiomyopathy (PPCM) is a rare heart disease, occurring in previously heart‐healthy women during the last month of pregnancy or the first months after delivery due to left ventricular (LV) systolic dysfunction. A common pathomechanistic pathway of PPCM includes increased oxidative stress and the subsequent generation of a cleaved prolactin fragment (16 kDa PRL), which promotes the onset of heart failure (HF) in a microRNA (miR)‐146a‐dependent manner. Inhibition of prolactin secretion with the dopamine D2 receptor (D2R) agonist bromocriptine combined with standard HF therapy supports cardiac recovery. This study examined whether treatment with the more selective D2R agonist cabergoline prevents HF development in an experimental PPCM mouse model and might be used as an alternative treatment regime for PPCM. Methods and results: Postpartum (PP) female PPCM‐prone mice with a cardiomyocyte restricted STAT3‐deficiency (αMHC‐Cretg/+; Stat3fl/fl; CKO) were treated over two consecutive nursing periods with cabergoline (CKO Cab, 0.5 mg/kg/day) and were compared with bromocriptine treated CKO (CKO Br) and postpartum‐matched WT and CKO mice. Cabergoline treatment in CKO PP mice preserved cardiac function [fractional shortening (FS): CKO Cab: 34.5 ± 9.4% vs. CKO: 22.1 ± 9%, P < 0.05] and prevented the development of cardiac hypertrophy, fibrosis, and inflammation as effective as bromocriptine therapy (FS: CKO Br: 33.4 ± 5.6%). The myocardial up‐regulation of the PPCM biomarkers plasminogen inhibitor activator 1 (PAI‐1) and miR‐146a were prevented by both cabergoline and bromocriptine therapy. A small cohort of three PPCM patients from the German PPCM Registry was treated with cabergoline (1 mg per week for 2 weeks, followed by 0.5 mg per week for another 6 weeks) due to a temporary unavailability of bromocriptine. All PPCM patients initially presented with a severely reduced LV ejection fraction (LVEF: 26 ± 2%). However, at 6 months of follow‐up, LV function (LVEF: 56 ± 2%) fully recovered in all three PPCM patients, and no adverse events were detected. Conclusions: In the experimental PPCM mouse model, the selective D2R agonist cabergoline prevents the onset of postpartum HF similar to bromocriptine. In PPCM patients, cabergoline treatment was safe and effective as all patients fully recovered. Cabergoline might serve as a promising alternative to bromocriptine. However, these findings are based on experimental data and a small case series and thus have to be interpreted with caution and should be validated in a larger clinical trial. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart
- Author
-
Kirchhoff, Hanna, primary, Ricke-Hoch, Melanie, additional, Wohlan, Katharina, additional, Pietzsch, Stefan, additional, Karsli, Ümran, additional, Erschow, Sergej, additional, Zweigerdt, Robert, additional, Ganser, Arnold, additional, Eder, Matthias, additional, Scherr, Michaela, additional, and Hilfiker-Kleiner, Denise, additional
- Published
- 2022
- Full Text
- View/download PDF
7. Venetoclax and dexamethasone synergize with inotuzumab ozogamicin–induced DNA damage signaling in B-lineage ALL
- Author
-
Kirchhoff, Hanna, primary, Karsli, Uemran, additional, Schoenherr, Caroline, additional, Battmer, Karin, additional, Erschow, Sergej, additional, Talbot, Steven R., additional, Steinemann, Doris, additional, Heuser, Michael, additional, Heidenreich, Olaf, additional, Hilfiker-Kleiner, Denise, additional, Ganser, Arnold, additional, Eder, Matthias, additional, and Scherr, Michaela, additional
- Published
- 2021
- Full Text
- View/download PDF
8. Increased prostaglandin-D2 in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation
- Author
-
Stelling, Elisabeth, primary, Ricke-Hoch, Melanie, additional, Erschow, Sergej, additional, Hoffmann, Steve, additional, Bergmann, Anke Katharina, additional, Heimerl, Maren, additional, Pietzsch, Stefan, additional, Battmer, Karin, additional, Haase, Alexandra, additional, Stapel, Britta, additional, Scherr, Michaela, additional, Balligand, Jean-Luc, additional, Binah, Ofer, additional, and Hilfiker-Kleiner, Denise, additional
- Published
- 2020
- Full Text
- View/download PDF
9. Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
- Author
-
Scherr, Michaela, primary, Kirchhoff, Hanna, additional, Battmer, Karin, additional, Wohlan, Katharina, additional, Lee, Chun-Wei, additional, Ricke-Hoch, Melanie, additional, Erschow, Sergej, additional, Law, Edward, additional, Kloos, Arnold, additional, Heuser, Michael, additional, Ganser, Arnold, additional, Hilfiker-Kleiner, Denise, additional, Heidenreich, Olaf, additional, and Eder, Matthias, additional
- Published
- 2018
- Full Text
- View/download PDF
10. Optimized Induction of Mitochondrial Apoptosis By Combination Therapies with Venetoclax for Chemotherapy-Free Treatment of BCR-ABL+ Acute Lymphoblastic Leukemia in Preclinical Models
- Author
-
Eder, Matthias, primary, Kirchhoff, Hanna, additional, Battmer, Karin, additional, Wohlan, Katharina, additional, Ricke-Hoch, Melanie, additional, Erschow, Sergej, additional, Law, Edward, additional, Kloos, Arnold, additional, Heuser, Michael, additional, Ganser, Arnold, additional, Hilfiker-Kleiner, Denise, additional, Heidenreich, Olaf, additional, and Scherr, Michaela, additional
- Published
- 2018
- Full Text
- View/download PDF
11. Increased prostaglandin-D2 in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation.
- Author
-
Stelling, Elisabeth, Ricke-Hoch, Melanie, Erschow, Sergej, Hoffmann, Steve, Bergmann, Anke Katharina, Heimerl, Maren, Pietzsch, Stefan, Battmer, Karin, Haase, Alexandra, Stapel, Britta, Scherr, Michaela, Balligand, Jean-Luc, Binah, Ofer, and Hilfiker-Kleiner, Denise
- Subjects
HEART cells ,PROGENITOR cells ,ENDOTHELIAL cells ,ANDROGEN receptors ,WHITE adipose tissue ,PROSTAGLANDIN receptors ,MALES - Abstract
Cardiac levels of the signal transducer and activator of transcription factor-3 (STAT3) decline with age, and male but not female mice with a cardiomyocyte-specific STAT3 deficiency conditional knockout (CKO) display premature age-related heart failure associated with reduced cardiac capillary density. In the present study, isolated male and female CKO-cardiomyocytes exhibit increased prostaglandin (PG)-generating cyclooxygenase-2 (COX-2) expression. The PG-degrading hydroxyprostaglandin-dehydrogenase-15 (HPGD) expression is only reduced in male cardiomyocytes, which is associated with increased prostaglandin D
2 (PGD2 ) secretion from isolated male but not female CKO-cardiomyocytes. Reduced HPGD expression in male cardiomyocytes derive from impaired androgen receptor (AR)–signaling due to loss of its cofactor STAT3. Elevated PGD2 secretion in males is associated with increased white adipocyte accumulation in aged male but not female hearts. Adipocyte differentiation is enhanced in isolated stem cell antigen-1 (SCA-1)+ cardiac progenitor cells (CPC) from young male CKO-mice compared with the adipocyte differentiation of male wild-type (WT)-CPC and CPC isolated from female mice. Epigenetic analysis in freshly isolated male CKO-CPC display hypermethylation in pro-angiogenic genes (Fgfr2, Epas1) and hypomethylation in the white adipocyte differentiation gene Zfp423 associated with up-regulated ZFP423 expression and a shift from endothelial to white adipocyte differentiation compared with WT-CPC. The expression of the histone-methyltransferase EZH2 is reduced in male CKO-CPC compared with male WT-CPC, whereas no differences in the EZH2 expression in female CPC were observed. Clonally expanded CPC can differentiate into endothelial cells or into adipocytes depending on the differentiation conditions. ZFP423 overexpression is sufficient to induce white adipocyte differentiation of clonal CPC. In isolated WT-CPC, PGD2 stimulation reduces the expression of EZH2, thereby up-regulating ZFP423 expression and promoting white adipocyte differentiation. The treatment of young male CKO mice with the COX inhibitor Ibuprofen or the PGD2 receptor (DP)2 receptor antagonist BAY-u 3405 in vivo increased EZH2 expression and reduced ZFP423 expression and adipocyte differentiation in CKO-CPC. Thus, cardiomyocyte STAT3 deficiency leads to age-related and sex-specific cardiac remodeling and failure in part due to sex-specific alterations in PGD2 secretion and subsequent epigenetic impairment of the differentiation potential of CPC. Causally involved is the impaired AR signaling in absence of STAT3, which reduces the expression of the PG-degrading enzyme HPGD. Impaired androgen-receptor-signaling due to STAT3-deficiency promotes increased prostaglandin-D2-secretion from male but not female cardiomyocytes; this induces an epigenetic switch in cardiac progenitor cells from endothelial to white adipocyte differentiation, associated with reduced cardiac capillary density, increased cardiac white fat deposits and heart failure in aged male but not female mice. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
12. Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
- Author
-
Stapel, Britta, primary, Kohlhaas, Michael, additional, Ricke-Hoch, Melanie, additional, Haghikia, Arash, additional, Erschow, Sergej, additional, Knuuti, Juhani, additional, Silvola, Johanna M. U., additional, Roivainen, Anne, additional, Saraste, Antti, additional, Nickel, Alexander G., additional, Saar, Jasmin A., additional, Sieve, Irina, additional, Pietzsch, Stefan, additional, Müller, Mirco, additional, Bogeski, Ivan, additional, Kappl, Reinhard, additional, Jauhiainen, Matti, additional, Thackeray, James T., additional, Scherr, Michaela, additional, Bengel, Frank M., additional, Hagl, Christian, additional, Tudorache, Igor, additional, Bauersachs, Johann, additional, Maack, Christoph, additional, and Hilfiker-Kleiner, Denise, additional
- Published
- 2016
- Full Text
- View/download PDF
13. Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.
- Author
-
Stapel, Britta, Kohlhaas, Michael, Ricke-Hoch, Melanie, Haghikia, Arash, Erschow, Sergej, Knuuti, Juhani, Silvola, Johanna M. U., Roivainen, Anne, Saraste, Antti, Nickel, Alexander G., Saar, Jasmin A., Sieve, Irina, Pietzsch, Stefan, Müller, Mirco, Bogeski, Ivan, Kappl, Reinhard, Jauhiainen, Matti, Thackeray, James T., Scherr, Michaela, and Bengel, Frank M.
- Abstract
AimsThe benefit of the β
1 -adrenergic receptor (β1 -AR) agonist dobutamine for treatment of acute heart failure in peripartum cardiomyopathy (PPCM) is controversial. Cardiac STAT3 expression is reduced in PPCM patients. Mice carrying a cardiomyocyte-restricted deletion of STAT3 (CKO) develop PPCM. We hypothesized that STAT3-dependent signalling networks may influence the response to β-AR agonist treatment in PPCM patients and analysed this hypothesis in CKO mice.Methods and resultsFollow-up analyses in 27 patients with severe PPCM (left ventricular ejection fraction ≤25%) revealed that 19 of 20 patients not obtaining dobutamine improved cardiac function. All seven patients obtaining dobutamine received heart transplantation (n = 4) or left ventricular assist devices (n = 3). They displayed diminished myocardial triglyceride, pyruvate, and lactate content compared with non-failing controls. The β-AR agonist isoproterenol (Iso) induced heart failure with high mortality in postpartum female, in non-pregnant female and in male CKO, but not in wild-type mice. Iso induced heart failure and high mortality in CKO mice by impairing fatty acid and glucose uptake, thereby generating a metabolic deficit. The latter was governed by disturbed STAT3-dependent signalling networks, microRNA-199a-5p, microRNA-7a-5p, insulin/glucose transporter-4, and neuregulin/ErbB signalling. The resulting cardiac energy depletion and oxidative stress promoted dysfunction and cardiomyocyte loss inducing irreversible heart failure, which could be attenuated by the β1 -AR blocker metoprolol or glucose-uptake-promoting drugs perhexiline and etomoxir.ConclusionsIso impairs glucose uptake, induces energy depletion, oxidative stress, dysfunction, and death in STAT3-deficient cardiomyocytes mainly via β1 -AR stimulation. These cellular alterations may underlie the dobutamine-induced irreversible heart failure progression in PPCM patients who frequently display reduced cardiac STAT3 expression. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
14. Optimized Induction of Mitochondrial Apoptosis By Combination Therapies with Venetoclax for Chemotherapy-Free Treatment of BCR-ABL+Acute Lymphoblastic Leukemia in Preclinical Models
- Author
-
Eder, Matthias, Kirchhoff, Hanna, Battmer, Karin, Wohlan, Katharina, Ricke-Hoch, Melanie, Erschow, Sergej, Law, Edward, Kloos, Arnold, Heuser, Michael, Ganser, Arnold, Hilfiker-Kleiner, Denise, Heidenreich, Olaf, and Scherr, Michaela
- Abstract
Background: BCR-ABL+acute lymphoblastic leukemia (ALL) in adults has a poor prognosis with allogeneic stem cell transplantation (SCT) considered the best curative option for suitable patients. BH3 mimetics induce mitochondrial outer membrane permeabilization (MOMP) linked to apoptosis induction by releasing BH3-only proteins BIM and/or BID from the anti-apoptotic factors BCL2, BCL-XL, MCL1, BCLW and BFL1. The BCL2-specific BH3 mimetic venetoclax (ABT-199) may provide an opportunity to improve pharmacotherapy of BCR-ABL+ALL in particular for elderly patients not suitable for SCT.
- Published
- 2018
- Full Text
- View/download PDF
15. Vitamin A preserves cardiac energetic gene expression in a murine model of diet-induced obesity.
- Author
-
Naasner L, Froese N, Hofmann W, Galuppo P, Werlein C, Shymotiuk I, Szaroszyk M, Erschow S, Amanakis G, Bähre H, Kühnel MP, Jonigk DD, Geffers R, Seifert R, Ricke-Hoch M, Wende AR, Blaner WS, Abel ED, Bauersachs J, and Riehle C
- Subjects
- Mice, Animals, Vitamin A, Disease Models, Animal, Diet, Obesity genetics, Gene Expression, Vitamins, Diabetic Cardiomyopathies, Diabetes Mellitus, Type 2
- Abstract
Perturbed vitamin-A metabolism is associated with type 2 diabetes and mitochondrial dysfunction that are pathophysiologically linked to the development of diabetic cardiomyopathy (DCM). However, the mechanism, by which vitamin A might regulate mitochondrial energetics in DCM has previously not been explored. To test the hypothesis that vitamin-A deficiency accelerates the onset of cardiomyopathy in diet-induced obesity (DIO), we subjected mice with lecithin retinol acyltransferase (Lrat) germline deletion, which exhibit impaired vitamin-A stores, to vitamin A-deficient high-fat diet (HFD) feeding. Wild-type mice fed with a vitamin A-sufficient HFD served as controls. Cardiac structure, contractile function, and mitochondrial respiratory capacity were preserved despite vitamin-A deficiency following 20 wk of HFD feeding. Gene profiling by RNA sequencing revealed that vitamin A is required for the expression of genes involved in cardiac fatty acid oxidation, glycolysis, tricarboxylic acid cycle, and mitochondrial oxidative phosphorylation in DIO as expression of these genes was relatively preserved under vitamin A-sufficient HFD conditions. Together, these data identify a transcriptional program, by which vitamin A preserves cardiac energetic gene expression in DIO that might attenuate subsequent onset of mitochondrial and contractile dysfunction. NEW & NOTEWORTHY The relationship between vitamin-A status and the pathogenesis of diabetic cardiomyopathy has not been studied in detail. We assessed cardiac mitochondrial respiratory capacity, contractile function, and gene expression by RNA sequencing in a murine model of combined vitamin-A deficiency and diet-induced obesity. Our study identifies a role for vitamin A in preserving cardiac energetic gene expression that might attenuate subsequent development of mitochondrial and contractile dysfunction in diet-induced obesity.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.